Effectiveness of Colchicine Among Patients With COVID-19 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 8, 2021

Primary Completion Date

June 18, 2021

Study Completion Date

June 18, 2021

Conditions
Coronavirus Infection
Interventions
DRUG

Colchicine 0.5 MG

participant will be given a Colchicine regimen in a dose of 0.5mg twice daily for 14 days or until symptoms subsides,those with low body weight and develop side effect like diarrhea and vomiting dose will be reduced and supportive treatment will be given .

DRUG

usual care treatment

control group will receive usual care COVID-19 treatment according to Iraqi protocol guideline and will not receive colchicine.

Trial Locations (1)

44001

Hawler medical university ,Rozhawa emergency hospital, Erbil

All Listed Sponsors
lead

Hawler Medical University

OTHER